CRDF Q1 2017 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$133M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$95,038-21.1% YoY

Gross Profit

-$521,388-548.6% margin

Operating Income

-$10M-10654.3% margin

Net Income

-$10M-10521.6% margin

EPS (Diluted)

$-23.25

QoQ Revenue Growth

+39.8%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$920,799

Balance Sheet

Total Assets

$34M

Total Liabilities

$23M

Stockholders' Equity

$11M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$95,038	$120,486	-21.1%
Gross Profit	-$521,388	-$188,785	-176.2%
Operating Income	-$10M	-$10M	+3.2%
Net Income	-$10M	-$10M	+2.6%